Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

An online dedicated therapeutics peer review session for College members who are qualified independent prescribers.

Adrian O’Dowd considers what optometrists should bear in mind when prescribing treatments that may have serious side effects.

Acting with honesty and integrity to maintain public trust and confidence in the profession is vital, but as optometry evolves and professionals take on more diverse roles than ever, lines may become blurred. Helen Gilbert investigates how to safeguard against conflicts of interest.